Liposome-targeted recombinant human acid sphingomyelinase: Production, formulation, and in vitro evaluation-Reference-Cited by-同舟云学术

Liposome-targeted recombinant human acid sphingomyelinase: Production, formulation, and in vitro evaluation

Published:2019-04 Issue: Volume:137 Page:185-195
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Aldosari Mohammed H.,de Vries Robert P.,Rodriguez Lucia R.,Hesen Nienke A.,Beztsinna Nataliia,van Kuilenburg André B.P.,Hollak Carla E.M.,Schellekens Huub,Mastrobattista Enrico

Funder

Saudi Food and Drug Authority

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference56 articles.

1. Types A and B Niemann-Pick disease;Schuchman;Mol. Genet. Metab.,2017

2. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease;Schuchman;J. Inherit. Metab. Dis.,2007

3. Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease);Otterbach;Cell,1995

4. Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD);McGovern;Orphanet J. Rare Dis.,2017

5. Ultra orphan drugs: the NHS model for managing extremely rare diseases;Jessop;Expert Opin. Orphan Drugs,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders;Advanced Drug Delivery Reviews;2023-06

2. Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish;International Journal of Molecular Sciences;2023-03-01

3. Olipudase alfa approved for pediatric and adult patients with acid sphingomyelinase deficiency (ASMD): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG);Genetics in Medicine Open;2023

4. Liposomal formulations for treating lysosomal storage disorders;Advanced Drug Delivery Reviews;2022-11

5. Current treatment options and novel nanotechnology-driven enzyme replacement strategies for lysosomal storage disorders;Advanced Drug Delivery Reviews;2022-09